FLGT Logo

Fulgent Genetics, Inc. (FLGT) 

NASDAQ
Market Cap
$681.07M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
542 of 776
Rank in Industry
33 of 42

Largest Insider Buys in Sector

FLGT Stock Price History Chart

FLGT Stock Performance

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related …

Insider Activity of Fulgent Genetics, Inc.

Over the last 12 months, insiders at Fulgent Genetics, Inc. have bought $0 and sold $994,939 worth of Fulgent Genetics, Inc. stock.

On average, over the past 5 years, insiders at Fulgent Genetics, Inc. have bought $0 and sold $7.23M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 17,478 shares for transaction amount of $43,240 was made by Hsieh Ming (President and CEO) on 2019‑03‑05.

List of Insider Buy and Sell Transactions, Fulgent Genetics, Inc.

2024-09-03SaleChief Scientific Officer
1,503
0.005%
$21.96$33,007-3.11%
2024-09-03SalePresident and COO
1,594
0.0053%
$21.96$35,006-3.11%
2024-09-03SaleCFO and Treasurer
1,674
0.0056%
$21.96$36,763-3.11%
2024-08-27SaleChief Scientific Officer
563
0.0019%
$22.83$12,855-6.38%
2024-08-27SaleChief Executive Officer
2,313
0.0076%
$22.83$52,813-6.38%
2024-08-27SalePresident and COO
715
0.0024%
$22.83$16,326-6.38%
2024-08-27SaleCFO and Treasurer
733
0.0024%
$22.83$16,737-6.38%
2023-12-11SalePresident and COO
22,000
0.0746%
$26.52$583,453-16.36%
2023-12-04SaleChief Scientific Officer
1,437
0.0049%
$27.57$39,623-19.80%
2023-12-04SalePresident and COO
1,779
0.006%
$27.57$49,053-19.80%
2023-12-04SaleCFO and Treasurer
1,437
0.0049%
$27.57$39,623-19.80%
2023-11-16SalePresident and COO
1,617
0.0054%
$27.25$44,065-18.96%
2023-11-16SaleCFO and Treasurer
1,307
0.0043%
$27.25$35,617-18.96%
2023-09-07SaleChief Scientific Officer
1,041
0.0035%
$31.41$32,696-24.20%
2023-09-07SalePresident and COO
1,492
0.005%
$31.41$46,861-24.20%
2023-09-07SaleCFO and Treasurer
1,492
0.005%
$31.41$46,861-24.20%
2023-08-28SaleCFO and Treasurer
10,299
0.0344%
$33.62$346,297-27.04%
2023-08-17SaleChief Scientific Officer
342
0.0011%
$33.88$11,587-27.40%
2023-08-17SalePresident and COO
1,307
0.0043%
$33.88$44,283-27.40%
2023-08-17SaleCFO and Treasurer
1,798
0.0059%
$33.88$60,918-27.40%

Insider Historical Profitability

22.28%
Hsieh MingChief Executive Officer
707275
2.3345%
$22.48182+22.28%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$85.08M13.13.92M+4.22%+$3.44M<0.01
The Vanguard Group$30.91M4.761.42M+0.58%+$179,176.91<0.01
Dimensional Fund Advisors$29.19M4.51.35M-7.06%-$2.22M0.01
State Street$17.89M2.76824,477+1.42%+$250,526.50<0.01
Park West Asset Management Llc$15.84M2.44729,783+71.8%+$6.62M1.19
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.